Peer-Reviewed Literature Synthesis

Low Back Pain Biomarker Atlas

Molecular alterations reported in Low Back Pain compared to healthy controls, from peer-reviewed literature.

Spontaneous remission~90% of acute LBP episodes resolve within 6 weeks regardless of treatment; chronic LBP (>3 months) shows only 30-40%…
Best-intervention remissionCognitive behavioral therapy (CBT) + graded exercise: 50-70% sustained improvement at 1 year in chronic LBP; Pain…
Gap sizeLarge for psychologically-informed approaches vs current opioid/surgical dominant model
Primary barrierpractice
Full remission profile →

Literature Overview

Biomarkers below are included only where peer-reviewed literature explicitly reports the marker's direction in Low Back Pain patients relative to a named comparison population — not inferred.

2
Curated markers
1
Categories

Searchable Alterations Database

Comparison populations are quoted as reported in the source literature (e.g. healthy controls, disease-matched patients).

Marker / TestDirectionCategoryvs. ComparisonClinical ContextKey Reference

Key References

Peer-Reviewed Literature

Lim et al. 2020

DOI: 10.1097/AJP.0000000000000810 →
Peer-Reviewed Literature

Injeyan et al. 2025

DOI: 10.1177/11772719251355038 →
Disclaimer: Educational synthesis of peer-reviewed literature only — not medical advice. Markers are drawn from published disease-vs-comparison-population studies; inclusion here does not imply diagnostic or clinical validation. Consult a qualified healthcare professional for interpretation.

Part of the Open Source Medicine Foundation Network

Open Source Medicine Foundation The OSMF hub — advancing open-source biomedical research infrastructure, tools, and evidence synthesis.
SpikeProtein.site Database and research resource on SARS-CoV-2 spike protein biology, persistence, and clinical implications.
Vaccine Data Navigator Open-access navigation tool for vaccine adverse event reporting and surveillance data.
PACVS Research Summit Annual summit convening researchers, clinicians, and patients on PACVS science.